FDAFDA · Food and drugs·Recall number D-0174-2025
phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25
Published January 8, 2025 · Recall initiated: December 19, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Hikma Injectables USA Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot number: 243120003D, Use by Date: 03/11/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.